Cagrilintide CAS 1415456-99-3 with COA

Skelbimo nr. 297963, įdėtas 2025-04-18 · Perskaitė:

Research tool for obesity mechanisms and combination therapy development.
Pharmaceutical candidate for metabolic disorders, including type 2 diabetes and obesity-related comorbidities.

Kaina: 30 EUR

Kontaktai

Vardas: Cathy
Miestas: Rokiškis
Telefonas: +8619162907953

El. paštas: